Predicting memory decline in Alzheimer's patients
Part of Brain & nervous system, Mental health clinical trials.
This study looks at what factors might predict how quickly memory and thinking skills decline in people with Alzheimer's disease. It uses results from a standard memory test (MMSE) taken at two different times, one year apart, to understand patterns of decline.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of Alzheimer's disease based on current medical guidelines.
- You have taken the MMSE (a memory and thinking test) at least twice, with tests given about one year apart.
- You receive follow-up care at the Memory Clinic of CH Gonesse in France.
- You do not have another brain disease such as frontotemporal dementia, Lewy body dementia, or vascular dementia.
- You have not moved away from the area served by CH Gonesse.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how “slower movement” and brain changes relate to memory and thinking problems in people with early dementia (and some related conditions). It may help researchers understand what brain differences go with these symptoms, using tests and an MRI scan.
This study tests quick new methods to measure “slowed actions” in people with stroke or memory-related brain conditions. The goal is to see whether these quick tests can help predict future outcomes and guide care.
This trial studies people diagnosed with Alzheimer’s disease who are at a moderate stage of decline. It likely involves cognitive (memory/thinking) testing and care-partner input to help track changes over time.
This study tests strategies to prevent Alzheimer's disease in people with early memory concerns. It may help if you notice your thinking is not as sharp as before, but you can still manage daily tasks on your own.
This study uses a computer-based platform to test memory and thinking in healthy adults and in people with mild memory concerns (called aMCI). The goal is to better understand how memory changes with age and to spot early signs of Alzheimer's disease.
This study follows people over time to better understand how memory and thinking complaints progress in early Alzheimer’s disease (from “subjective cognitive decline” to mild cognitive problems). It may help researchers understand who is likely to decline and how symptoms change, which could support future treatments.
Hear when a new Cognitive Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.